Relationships between Cholesterol, Apolipoprotein E Polymorphism and Dementia: A Cross-Sectional Analysis from the PAQUID Study

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Neuroepidemiology

• Publication date

  2000-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000026249PMID 10705232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of Apolipoprotein E ε4 in the Relationships of Smoking and Drinking to Cognitive Function

  1999cited by this paper
• The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive function.

  1999cited by this paper
• Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

  1998cited by this paper
• Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.

  1998cited by this paper
• Alzheimer's disease

  1998cited by this paper
• Gene-Environment Interaction in Alzheimer’s Disease:A Potential Role for Cholesterol

  1998cited by this paper
• Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons.

  1998cited by this paper
• Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.

  1998cited by this paper
• Reduced Levels of Cholesterol, Phospholipids, and Fatty Acids in Cerebrospinal Fluid of Alzheimer Disease Patients Are Not Related to Apolipoprotein E4

  1998cited by this paper
• Caloric Intake and Aging

  1997cited by this paper
• Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging.

  1997cited by this paper
• Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men.

  1997cited by this paper
• Dietary fat intake and the risk of incident dementia in the Rotterdam study

  1997cited by this paper
• LOWER SERUM CHOLESTEROL LEVEL AND LATER DECLINE IN COGNITIVE FUNCTION IN OLDER PEOPLE LIVING IN THE COMMUNITY, JAPAN

  1997cited by this paper
• Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.

  1997cited by this paper
• SERUM CHOLESTEROL LEVELS AND COGNITIVE FUNCTION ASSESSED BY P300 LATENCIES IN AN OLDER POPULATION LIVING IN THE COMMUNITY

  1997cited by this paper
• Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study.

  1997cited by this paper
• Weight Loss Precedes Dementia in Community‐Dwelling Older Adults

  1996cited by this paper
• Weight loss precedes dementia in community-dwelling older adults.

  1996cited by this paper
• Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease.

  1996cited by this paper
• Relationships between macronutrient intake, handicaps, and cognitive impairments in free living elderly people

  1995cited by this paper
• HDL Apolipoprotein A-I Attenuates Oxidative Modification of Low Density Lipoprotein: Studies in Transgenic Mice

  1995cited by this paper
• Do Low Cholesterol Levels Slow Mental Processing?

  1995cited by this paper
• Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA.

  1994cited by this paper
• The Paquid epidemiological program on brain ageing.

  1992cited by this paper
• Serum lipoprotein pattern variations in dementia and ischemic stroke

  1990cited by this paper
• High-density lipoprotein cholesterol levels of very old people in the diagnosis of dementia.

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• High-density lipoprotein cholesterol is associated with lowered cognitive recovery among acute ischemic stroke patients with mild cognitive impairment

  2023cites this paper
• Risk factors for stroke outcomes in adults: Stroke in China

  2023cites this paper
• Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease

  2022cites this paper
• Metabolic Syndrome: Is It Time to Add the Central Nervous System?

  2021cites this paper
• Lipid effects during antipsychotic drug treatment and their relevance for clinical outcomes

  2020cites this paper
• Acute exercise increases circulating IGF-1 in Alzheimer's disease patients, but not in older adults without dementia.

  2020cites this paper
• The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease

  2020cites this paper
• How stress mediators can cumulatively contribute to Alzheimer’s disease An allostatic load approach

  2019cites this paper
• Relationship between mobility and cognitive impairment in patients with Alzheimer's disease.

  2019cites this paper
• Associations Between the Apolipoprotein E ε4 Allele and Reduced Serum Levels of High Density Lipoprotein a Cognitively Normal Aging Han Chinese Population

  2019cites this paper
• Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients

  2019cites this paper
• The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up

  2019cites this paper
• CPMCGLM: an R package for p-value adjustment when looking for an optimal transformation of a single explanatory variable in generalized linear models

  2019cites this paper
• Rosuvastatin ameliorates cognitive impairment in rats fed with high-salt and cholesterol diet via inhibiting acetylcholinesterase activity and amyloid beta peptide aggregation

  2018cites this paper
• The Role of ApoE Polymorphism in the Relationship between Serum Steroid Hormone Levels and Cognition in Older Chinese Adults: A Cross-Sectional Study

  2018cites this paper
• Shared pathological pathways of Alzheimer's disease with specific comorbidities: current perspectives and interventions

  2018cites this paper
• High Low-Density Lipoprotein Cholesterol Inversely Relates to Dementia in Community-Dwelling Older Adults: The Shanghai Aging Study

  2018cites this paper
• Association of Apolipoprotein E , Methylenetetrahydrofolate Genotypes , Lipids levels and Alzheimer Disease in an Algerian Population

  2017cites this paper
• Global gene expression changes in the prefrontal cortex of rabbits with hypercholesterolemia and/or hypertension

  2017cites this paper
• Impaired Insulin Sensitivity and Secretion in Patients with Alzheimer's Disease: The Relationship with Other Atherosclerosis Risk Factors.

  2017cites this paper
• Factors Associated with Mild Cognitive Impairment among Elderly Filipinos with Type 2 Diabetes Mellitus

  2017cites this paper
• Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study

  2017cites this paper
• Die @Bedeutung von Phospholipiden und oxidierten Lipiden für die Prozessierung des Amyloid-Vorläufer Proteins (APP) und die Alzheimer Krankheit

  2016influential citation
• Cortisol, HDL‐c, VLDL‐c, and APOE Polymorphisms as Laboratorial Parameters Associated to Cognitive Impairment No Dementia (CIND) and Dementia

  2016cites this paper
• Resistance Training, Lipid Profile, and Homocysteine in Patients with Alzheimer's Disease

  2016cites this paper
• Effect of apolipoprotein E (APO E) polymorphism on leptin in Alzheimer's disease

  2015cites this paper
• HDL and cognition in neurodegenerative disorders.

  2014cites this paper
• Regulation and transport of apolipoprotein A-I into the central nervous system and therapeutic potential in Alzheimer's disease

  2014cites this paper
• Impact of nutrition on cognition and its association with blood and brain Alzheimer disease related biomarkers

  2014cites this paper
• Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease

  2014cites this paper
• High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease.

  2014cites this paper
• Possible role of vascular risk factors in Alzheimer's disease and vascular dementia.

  2014cites this paper
• Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum.

  2014cites this paper
• Correction of the significance level when attempting multiple transformations of an explanatory variable in generalized linear models

  2013cites this paper
• Risk factors associated with cognitive decline in the elderly with type 2 diabetes: Baseline data analysis of the Japanese elderly diabetes intervention trial

  2012cites this paper
• A high cholesterol diet ameliorates hippocampus-related cognitive and pathological deficits in ovariectomized mice.

  2012cites this paper
• Role of lipoproteins and inflammation in cognitive decline: do they interact?

  2012cites this paper
• Cholesterol and Late-Life Cognitive Decline

  2012cites this paper
• The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1.

  2012cites this paper
• Current Epidemiological Approaches to the Metabolic-Cognitive Syndrome

  2012cites this paper
• ABCA1, apoE and apoA-I as potential therapeutic targets for treating Alzheimer’s disease

  2011cites this paper
• Serum lipid levels in patients with Alzheimer's disease.

  2011cites this paper
• Cognitive decline in late-life: biological markers and early identification of persons at risk for dementia

  2011cites this paper
• PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA MOTRICIDADE (BIODINÂMICA DA MOTRICIDADE HUMANA) EFEITOS DO TREINAMENTO COM PESOS NOS SINTOMAS DEPRESSIVOS E VARIÁVEIS METABÓLICAS EM PACIENTES COM DOENÇA DE ALZHEIMER

  2011cites this paper
• Current Serum Lipoprotein Levels and fMRI Response to Working Memory in Midlife

  2011cites this paper
• Non-psychiatric comorbidity associated with Alzheimer's disease.

  2011cites this paper
• Metabolic syndrome, mild cognitive impairment, and dementia.

  2011cites this paper
• Statins: multiple neuroprotective mechanisms in neurodegenerative diseases.

  2011cites this paper
• Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study.

  2010cites this paper
• Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1ΔE9 Mice*

  2010cites this paper
• Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging

  2010cites this paper
• Spécificité de la dépression dans les démences

  2010cites this paper
• Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms

  2010cites this paper
• Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.

  2010cites this paper
• Cognitive decline: is there a protective role for nutrition and physical activity?

  2009cites this paper
• The influence of age on the association between cholesterol and cognitive function.

  2009cites this paper
• Decreased serum lipids in patients with probable Alzheimer's disease.

  2009cites this paper
• Total serum cholesterol levels and Alzheimer's dementia in patients with down syndrome

  2008cites this paper
• The role of diet on cognitive function in older adults

  2008cites this paper
• Metabolic Syndrome and Alzheimer's Disease: A Link to a Vascular Hypothesis?

  2008cites this paper
• Polymorphisms and Vascular Cognitive Impairment After Ischemic Stroke

  2007cites this paper
• [Risk factors and protective factors of the insanities].

  2007cites this paper
• Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan.

  2007cites this paper
• Serum lipoprotein profile and APOE genotype in Alzheimer's disease.

  2007cites this paper
• Beyond Cholesterol: Statin Benefits in Alzheimer's Disease

  2007cites this paper
• Facteurs de risque et facteurs protecteurs des démences

  2007cites this paper
• Aging without Dementia

  2006cites this paper
• Lipid metabolism in Alzheimer’s and Parkinson’s disease

  2006cites this paper
• Hematologic Risk Factors of Vascular Disease and Their Relation to Dementia

  2006cites this paper
• Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.

  2006cites this paper
• Apolipoprotein E ε4 Allele Is Associated with Vascular Dementia

  2006cites this paper
• Invited Commentary Invited Commentary: Lipoproteins and Dementia—Is It the Apolipoprotein A-I?

  2006cites this paper
• Circulating biomarkers of cognitive decline and dementia.

  2006cites this paper
• Cholesterol and Alzheimer's disease--is there a relation?

  2006cites this paper
• Functional Vitamin E Deficiency in ApoE4 Patients with Alzheimer’s Disease

  2006cites this paper
• Lipid metabolism in cognitive decline and dementia.

  2006cites this paper
• Apolipoprotein E epsilon4 allele is associated with vascular dementia.

  2006cites this paper
• Are serum lipid and lipoprotein levels related to dementia?

  2005cites this paper
• The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease.

  2005cites this paper
• The SOLINUT study: analysis of the interaction between nutrition and loneliness in persons aged over 70 years.

  2005cites this paper
• Pathophysiology of Alzheimer's disease.

  2005cites this paper
• Serum lipids and hippocampal volume: The link to Alzheimer's disease?

  2004cites this paper
• Aspirin, NSAIDs, Risk of Dementia, and Influence of the Apolipoprotein E Epsilon 4 Allele in an Elderly Population

  2004cites this paper
• Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study.

  2004cites this paper
• The Liver X Receptor Ligand T0901317 Decreases Amyloid β Production in Vitro and in a Mouse Model of Alzheimer's Disease*

  2004cites this paper
• Apolipoprotein E, dementia and strokes.

  2003cites this paper
• Serum cholesterol, precursors and metabolites and cognitive performance in an aging population.

  2003cites this paper
• Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?

  2003cites this paper
• Association of biochemical values with morbidity in the elderly: a population‐based Swedish study of persons aged 82 or more years

  2003cites this paper
• Bedingungen der Erhaltung und Förderung von Selbst- ständigkeit im höheren Lebensalter (SIMA): Teil XX: Demenzrisiken

  2003cites this paper
• The Role of Cardiovascular Risk Factors in Alzheimer's Disease

  2003cites this paper
• Apolipoprotein E, angiotensin-converting enzyme and alpha-1-antichymotrypsin genotypes are not associated with post-stroke dementia.

  2003cites this paper
• Alzheimer's Disease: Search for Therapeutics

  2003cites this paper
• Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity.

  2003cites this paper
• Dementia, the fate of brain? Neuropathological point of view.

  2002cites this paper
• Gene dose effect of the APOE-epsilon4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease.

  2002cites this paper
• Vascular basis of Alzheimer's pathogenesis.

  2002cites this paper
• Association between high‐density lipoprotein and cognitive impairment in the oldest old

  2002cites this paper
• Erkrankungen, die zu einer organischen psychischen Störung führen können

  2002cites this paper
• Impact of atherosclerosis and inflammation on cognitive function : the Leiden 85-plus study

  2002cites this paper